HomeNWRN • SWX
add
Newron Pharmaceuticals SpA
Previous close
CHF 15.50
Day range
CHF 14.80 - CHF 15.30
Year range
CHF 5.20 - CHF 31.85
Market cap
317.59M CHF
Avg Volume
107.33K
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 3.61M | -84.94% |
Operating expense | 6.64M | -6.07% |
Net income | -6.58M | -151.83% |
Net profit margin | -182.15 | -444.07% |
Earnings per share | — | — |
EBITDA | -3.02M | -117.81% |
Effective tax rate | -7.07% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.88M | 193.87% |
Total assets | 40.06M | -37.32% |
Total liabilities | 51.19M | -18.03% |
Total equity | -11.14M | — |
Shares outstanding | 20.01M | — |
Price to book | -27.68 | — |
Return on assets | -18.86% | — |
Return on capital | -27.94% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -6.58M | -151.83% |
Cash from operations | -502.00K | 88.57% |
Cash from investing | -55.50K | -109.66% |
Cash from financing | -6.67M | -299.87% |
Net change in cash | -7.23M | -1,399.17% |
Free cash flow | -2.50M | -125.06% |
About
CEO
Founded
1999
Website
Employees
27
